A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
No Data Available.
Synonyms :
Cefdinir
Class :
Cephalosporins and 3rd Generation
AdultÂ
Dosage Forms & StrengthsÂ
Oral suspensionÂ
125mg/5mlÂ
250mg/5mlÂ
CapsuleÂ
300 mgÂ
Dosage Forms & StrengthsÂ
Oral suspensionÂ
125mg/5mlÂ
250mg/5mlÂ
CapsuleÂ
300 mgÂ
Refer to the adult dosingÂ
may diminish concentration of serum when combined with cefdinir
may diminish concentration of serum when combined with cefdinir
may diminish concentration of serum when combined with cefdinir
may diminish concentration of serum when combined with cefdinir
cefdinir: they may diminish the absorption of antacids
cefdinir: they may diminish the absorption of antacids
cefdinir: they may diminish the absorption of antacids
cefdinir: they may diminish the absorption of antacids
cefdinir: they may diminish the absorption of antacids
may diminish the serum concentration of iron preparations
may diminish the absorption of Antacids
when both drugs are combined, there may be an increased effect of argatroban by anticoagulation
when both drugs are combined, there may be a reduced therapeutic effect of the vaccine  
when both drugs are combined, there may be an increased effect of bivalirudin by anticoagulation  
when both drugs are combined, there may be a reduced therapeutic effect of the vaccine  
when both drugs are combined, there may be an increased effect of dalteparin by anticoagulation  
may decrease the serum concentration and decrease in the efficacy
when both drugs are combined, there may be a reduced effect of cefdinir by increasing gastric ph  
when both drugs are combined, there may be an increased risk of adverse effects  
bazedoxifene conjugated estrogens
when both drugs are combined, there may be an increased risk of adverse effects  
when both drugs are combined, there may be an increased risk of adverse effects  
when both drugs are combined, there may be an increased risk of adverse effects  
when both drugs are combined, there may be an increased risk of adverse effects  
when both drugs are combined, there may be an increased risk of adverse effects  
it may diminish the excretion rate when combined with estradiol valerate resulting in a greater serum level
may have an increased nephrotoxic effect when combined with aminoglycosides
neomycin/polymyxin B/bacitracin topical
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
may have an increased nephrotoxic effect when combined with aminoglycosides
cefdinir has the potential to reduce the rate of excretion of idebenone, leading to an elevation in levels of serum
When cefdinir is used together with ouabain, this leads to reduction in cefdinir excretion
cefdinir leads to a reduction in the rate of excretion of eucalyptus oil which leads to increased level of serum
cefdinir leads to a reduction in the rate of excretion of chromous sulfate, which leads to an increased level of serum
cefdinir leads to a reduction in the rate of excretion of pentaerythritol tetranitrate, which leads to an increased level of serum
cefdinir leads to a reduction in the rate of excretion of potassium perchlorate, which leads to an increased level of serum
cefdinir's therapeutic efficacy may be reduced when used in combination with almasilate
When both drugs are combined, there may be an increased risk or severity of adverse effects  
demeclocycline reduces the effects of bactericidal agents
doxycycline reduces the effects of bactericidal agents
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
cephalosporins increase the nephrotoxicity of aminoglycosides
It may enhance the risk of adverse effects when combined with Cephalosporins
cefdinir might lead to a reduction in the rate of excretion of telavancin, potentially leading to elevated levels of serum
when both drugs are combined, there may be an increased risk of adverse effects 
Cephalosporins have a six-member dihydro-thiazine ring, which provides more bactericidal activity than the five-member thiazolidine rings that make up penicillins. Â
Cefdinir inhibits the formation of cell walls by attaching itself to penicillin-binding proteins (PBPs), which results in bactericidal action.Â
Penicillin protein binding proteins 2 and 3 have demonstrated affinity for cefdinir. Â
Adverse drug reactions: Â
Frequency defined Â
>10% Â
Diarrhea  Â
1-10% Â
Vaginal moniliasis  Â
Nausea  Â
Rash  Â
Headache  Â
Increased urine leukocytes  Â
Increased urine protein  Â
Decreased lymphocytes  Â
Glycosuria  Â
Increased alkaline phosphatase  Â
Increased eosinophils Â
Increased platelets  Â
NoneÂ
Contraindication:Â
HypersensitivityÂ
Caution:Â
Penicillin allergyÂ
ColitisÂ
Pregnancy warnings:   Â
Breastfeeding warnings:Â
Pregnancy Categories:     Â
A bactericidal drug called cefdinir works by preventing the formation of bacterial cell walls.Â
Cefdinir is effective against a wide range of bacterial infections including gram-positive and gram-negative.Â
It works well against bacteria that produce the beta-lactamase enzyme. Cefdinir may therefore be vulnerable to a wide range of pathogens that are resistant to other cephalosporins.Â
It is administered through oral route in form of capsule and suspension.Â
It is taken with or without food. Shake oral suspension well before each use.Â
Generic Name: Cefdinir (Rx) Â
Pronounced: sÄ•f ′dÄ-nĂ®r′Â
Why do we use Cefdinir?Â
Cefdinir is indicated to treat acute bacterial otitis media, community-acquired pneumonia, pharyngitis/tonsillitis.Â
It is also used in treatment of acute maxillary sinusitis, and skin structure infections.Â